Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Intellia Therapeutics Analyst Ratings
Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals
Apellis Pharmaceuticals Analyst Ratings
Intellia Hereditary Angioedema Candidate Meets Phase 2 Primary Endpoint
BofA Upgrades Editas to Buy, Cites Reni-cel Progress
Cantor Fitzgerald Reiterates Neutral on CRISPR Therapeutics